DiscoverStartupsSafeguard ScientificsSafeguard Scientifics Funding Rounds, Valuation & Investors
Safeguard Scientifics company logo
Safeguard Scientifics
We help build great companies by providing growth capital and operational support11-50 Employees
View 0 jobs

Safeguard Scientifics Funding

$75M
11 round
Safeguard Scientifics is active in the following markets / industries: health care, finance and venture capital. The company has secured funding across 1 rounds, totaling in an amount of $75M. Their most recent funding was raised on May 12, 2017.

Funding Rounds

U
$75000000
UnknownMay 2017

Investments of Safeguard Scientifics

Moxe Health
Avatar for Moxe Health
Zipnosis
Avatar for Zipnosis
InfoBionic
Apprenda
Avatar for Apprenda
Velano Vascular
Clutch
Avatar for Clutch
Hoopla Software
Avatar for Hoopla Software
Crescendo Bioscience
Avatar for Crescendo Bioscience
Trice Medical
Avatar for Trice Medical
Weblinc
Quinnova Pharmaceuticals
Avatar for Quinnova Pharmaceuticals
Aventura HQ
meQuilibrium
Avatar for meQuilibrium
Sotera Wireless
Avatar for Sotera Wireless
Thingworx
Avatar for Thingworx
Tengion
Avatar for Tengion
Nextone Communications
Acquired by Genband Inc. (Previously NexTone/NextPoint)
Exit
E-Duction
Avatar for E-Duction
PixelOptics
Avatar for PixelOptics
QuantiaMD
Avatar for QuantiaMD
Nova Som
Avatar for Nova Som
Putney
Avatar for Putney
Pneuron
Avatar for Pneuron
Garnet Biotherapeutics
Avatar for Garnet Biotherapeutics
Avid Radiopharmaceuticals
Acquired by Eli Lilly
Avatar for Avid Radiopharmaceuticals
Exit
Molecular Biometrics
Avatar for Molecular Biometrics
Advanced BioHealing Inc.
Avatar for Advanced BioHealing Inc.
OfferWire
Avatar for OfferWire
AppFirst
Acquired
Avatar for AppFirst
Exit
Portico Systems
Acquired by McKesson
Avatar for Portico Systems
Exit
Swaptree
Avatar for Swaptree
Good Start Genetics
Acquired
Avatar for Good Start Genetics
Exit
Covacsis
Avatar for Covacsis
Weblinc E-Commerce
Avatar for Weblinc E-Commerce
Authentium
Avatar for Authentium
Transactis
Acquired
Avatar for Transactis
Exit
Back to People
Onwards to Jobs